UA123399U - PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE - Google Patents

PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE

Info

Publication number
UA123399U
UA123399U UAU201709138U UAU201709138U UA123399U UA 123399 U UA123399 U UA 123399U UA U201709138 U UAU201709138 U UA U201709138U UA U201709138 U UAU201709138 U UA U201709138U UA 123399 U UA123399 U UA 123399U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
medicinal
oral use
choline
alphoscerate
Prior art date
Application number
UAU201709138U
Other languages
Ukrainian (uk)
Inventor
Олександр Вікторович Доровський
Геннадій Геннадійович Хорунжий
Олег Миколайович Когута
Original Assignee
Товариство З Обмеженою Відповідальністю "Фармацевтична Група "Здоров'Я"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товариство З Обмеженою Відповідальністю "Фармацевтична Група "Здоров'Я" filed Critical Товариство З Обмеженою Відповідальністю "Фармацевтична Група "Здоров'Я"
Priority to UAU201709138U priority Critical patent/UA123399U/en
Publication of UA123399U publication Critical patent/UA123399U/en

Links

Abstract

Фармацевтична композиція має ноотропну активність та холіноміметичну дію у формі орального розчину, у якій активною речовиною є холін альфосцерат у концентрації від 8,0 до 25 (мас. %), а також фармацевтично прийнятні допоміжні речовини.The pharmaceutical composition has nootropic activity and cholinomimetic action in the form of an oral solution in which the active substance is choline alfoscerate at a concentration of 8.0 to 25 (wt.%), As well as pharmaceutically acceptable excipients.

UAU201709138U 2017-09-15 2017-09-15 PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE UA123399U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201709138U UA123399U (en) 2017-09-15 2017-09-15 PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201709138U UA123399U (en) 2017-09-15 2017-09-15 PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE

Publications (1)

Publication Number Publication Date
UA123399U true UA123399U (en) 2018-02-26

Family

ID=61523969

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201709138U UA123399U (en) 2017-09-15 2017-09-15 PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE

Country Status (1)

Country Link
UA (1) UA123399U (en)

Similar Documents

Publication Publication Date Title
PH12015502539B1 (en) Cenicriviroc compositions and methods of making and using the same
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
CO2019000945A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
EA201992162A1 (en) COMPOSITIONS BASED ON NIRAPARIB
EA201792592A1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN
EA201890654A1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS
CO2019000943A2 (en) Modulators of the nmda spiro-lactam receptor and use thereof
EA202090573A1 (en) COMPOSITIONS OF NIRAPARIBA
DOP2017000293A (en) ORODISPERSABLE DOSAGE UNIT CONTAINING A STETROL COMPONENT
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
EA201792591A1 (en) PHARMACEUTICAL PREPARATIONS
EA201591701A1 (en) COMBINATION OF ANTI-VIRAL DIRECT ACTION AND RIBAVIRIN FOR THE TREATMENT OF PATIENTS WITH HCV
EA201590797A1 (en) PREPARATIONS WITH THE MODIFIED PROBE RELEASE
EA201792237A1 (en) PHARMACEUTICAL COMPOSITIONS
MX2017005163A (en) Onapristone extended-release compositions and methods.
UA123399U (en) PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE
RU2013124416A (en) DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
EA201792170A1 (en) INDOLA DERIVATIVES
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
AR109693A1 (en) OPROZOMIB IMMEDIATE RELEASE FORMULATIONS
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
EA201692556A1 (en) STABILIZED DESMOPRESSIN
EA201800226A1 (en) PHARMACEUTICAL COMPOSITION POSSESSING ANXIOLYTIC AND MALICIOUS ACTION